Drug Type Small molecule drug |
Synonyms N-myristoylated -Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr |
Target |
Action inhibitors |
Mechanism PKCε inhibitors(protein kinase C epsilon inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Reperfusion Injury | Preclinical | United States | 01 Jun 2023 |